NCI Bertagnolli raises paylines, creates Clinical Trials Innovation Unit, and announces National Cancer Plan February 10, 2023Vol.49 No.06By Matthew Bin Han Ong
White House Biden places cancer in top spot on Unity Agenda; announces new Moonshot programs February 10, 2023Vol.49 No.06By Matthew Bin Han Ong
Guest Editorial A Super Bowl LVII challenge: It’s Chiefs/KU vs. Eagles/SKCC February 10, 2023Vol.49 No.06By Matthew Huesser and Christine Thomas
FreeIn the Archives “How We Do Harm:” Otis Brawley’s encounters with health disparities in Atlanta’s Grady Hospital February 10, 2023Vol.49 No.06
Conversation with The Cancer LetterFree Otis Brawley & Robert Winn discuss the killing of Tyre Nichols and the power dynamics in policing—and health care February 03, 2023Vol.49 No.05By Matthew Bin Han Ong
Guest Editorial Healing from gun violence in Asian America: What does love look like in a time of hate?天下太平 Peace under the celestial sky February 03, 2023Vol.49 No.05By Cevadne Lee
Exercising owner’s prerogative, City of Hope retires the Cancer Treatment Centers of America brand February 03, 2023Vol.49 No.05By Matthew Bin Han Ong
Trials & Tribulations MRI-guided radiotherapy for prostate cancer: Lessons from the MIRAGE trial February 03, 2023Vol.49 No.05By Amar U. Kishan
Black History MonthConversation with The Cancer LetterFree Richard Silvera is bridging advocacy and research through the Robert A. Winn Diversity in Clinical Trials Award Program February 03, 2023Vol.49 No.05By Robert A. Winn
FreeIn the Archives Black History Month: Justice, health equity, and systemic racism February 03, 2023Vol.49 No.05
